Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International -- Ignore unavailable to you. Want to Upgrade?

To: Joe Dancy who wrote (596)	12/20/1998 8:17:00 PM
From: Night Trader	Read Replies (1) \| Respond to of 696

Joe, glad to hear you're meeting the CEO on Monday. Some possible questions: 1. In his opinion what would be a fair price for BIOI for an acquirer. 2. Why hasn't there been more insider buying as the price has declined? 3. His estimate of the long term revenue and earnings growth rate for BIOI's core business i.e. outside of acquisitions. Thanks in advance. BTW I've emailed SI about changing the name of the thread (may even help the stock price!)

To: Joe Dancy who wrote (596)	12/21/1998 8:33:00 AM
From: Neville Doherty	Respond to of 696

Looking forward to your report, Joe.

To: Joe Dancy who wrote (596)	12/22/1998 1:53:00 AM
From: Timothy Grimes	Read Replies (1) \| Respond to of 696

You wrote: I wouldn't worry Tim, the listing issue becomes a problem when the stock goes below $1. If it does, they could do a reverse split. Reverse spilts are never good. I hope the company never considers that as a possibility. Almost all companies that do a reverse split appear to be a huge risk and stay out of favor on Wall Street. Please post your meeting highlights next week. Really the only thing we need to know is when and how they plan to show a profit again, and then show the double digit growth required of a micro cap. Amgen received some nice news last week, will BIOI realize any additional revenue from Amgen's prize? best, Tim